Bio-Techne Corporation, a leading provider of life science reagents, instruments, and services, is making waves in the global research and clinical diagnostic markets. The company operates through two segments, Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment focuses on developing and manufacturing biological reagents used in life science research and diagnostics. This includes cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. Additionally, this segment offers proteomic analytical tools for western blot and multiplexed ELISA workflows. The Diagnostics and Genomics segment, on the other hand, specializes in developing and manufacturing diagnostic products, including exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays, genetic and oncology kits, and more. The company has also partnered with Lunaphore Technologies S.A. to develop an automated same-slide spatial multiomics solution. Founded in 1976 and headquartered in Minneapolis, Minnesota, Bio-Techne continues to revolutionize the life sciences industry.
Bio-Techne's ticker is TECH
The company's shares trade on the NASDAQ stock exchange
They are based in Minneapolis, Minnesota
There are 1001-5000 employees working at Bio-Techne
It is bio-techne.com
Bio-Techne is in the Healthcare sector
Bio-Techne is in the Biotechnology industry
The following five companies are Bio-Techne's industry peers: